Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Kidney international. Supplement

• Publication date

  1986-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 3458004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of parathyroid hormone secretion by aluminum.

  1983cited by this paper
• Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia.

  1983cited by this paper
• Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia.

  1983cited by this paper
• Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition.

  1983cited by this paper
• The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy.

  1982cited by this paper
• Histological quantitation of aluminum in iliac bone from patients with renal failure.

  1982cited by this paper
• Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism.

  1981cited by this paper
• Impaired parathyroid hormone metabolism in patients with chronic renal failure.

  1978cited by this paper
• Influence of dialysate calcium concentration and vitamin D on serum parathyroid hormone during repetitive dialysis.

  1975cited by this paper
• Quantitative histological studies on the pathogenesis of uremic bone disease.

  1974cited by this paper
• Hyperparathyroidism and renal failure.

  1973cited by this paper
• The treatment of renal osteodystrophy.

  1966cited by this paper
• The control of phosphate excretion in uremia.

  1966cited by this paper

• A Mouse Model of Adynamic Bone Disease (ABD) and its Consequences on Bone Quality with Age

  2015cites this paper
• Development, validation and characterization of a novel mouse model of Adynamic Bone Disease (ABD).

  2014cites this paper
• Long-term follow-up of parathyroidectomy for secondary hyperparathyr- oidism

  2009cites this paper
• Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies.

  2006cites this paper
• The renal bone diseases in children treated with dialysis.

  1996cites this paper
• Bone and mineral metabolism in childhood end-stage renal disease.

  1995cites this paper
• Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy.

  1995cites this paper
• ALUMINUM TOXICITY: A REVIEW IN RELATION TO CHRONIC RENAL FAILURE PATIENTS M AINTAINED ON REGULAR HEMODIALYSIS

  1993cites this paper
• Osteomalacia and rickets.

  1992cites this paper
• Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients.

  1991cites this paper
• Aluminum induced bone disease: Clinical features

  1990cites this paper
• Aluminum Bone Disease in Chronic Renal Failure

  1990cites this paper
• 二次性上皮小体機能亢進症に対する上皮小体摘除術の遠隔成績 -術後上皮小体機能低下症と, アルミニウム骨症発症の関係について-

  1989cites this paper
• Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide.

  1988cites this paper
• Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.

  1988cites this paper
• Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.

  1987cites this paper
• Bone histomorphometry of renal osteodystrophy in diabetic patients

  1987cites this paper
• Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine.

  1986cites this paper